Endothelial microparticles affect angiogenesis in vitro: Role of oxidative stress

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Mezentsev, Alexandre ^a,b   Merks, Roeland M H ^b   O'Riordan, Edmond ^a   Chen, Jun ^a   Mendelev, Natalia ^a   Goligorsky, Michael S ^a,b   Brodsky, Sergey V ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Angiogenesis; Cardiovascular disease; Diabetes; Human umbilical vein

Indexed keywords

ACETYLCHOLINE; BIOLOGICAL MARKER; MANGANESE DERIVATIVE; MANGANESE TETRAKIS(4 BENZOIC ACID)PORPHYRIN CHLORIDE; MATRIGEL; NITRIC OXIDE; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CAPILLARY DENSITY; CARDIOVASCULAR DISEASE; CELL ASSAY; CELL DIVISION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MEMBRANE VESICLE; MICROTUBULE; OXIDATIVE STRESS; PARAMETER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

APOPTOSIS; CELL DIVISION; CELL MEMBRANE; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; HUMANS; LAMININ; METALLOPORPHYRINS; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; PROTEOGLYCANS; SUPEROXIDE DISMUTASE; UMBILICAL VEINS;

EID: 23944476083     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00265.2005     Document Type: Article

References (41)

1. Abid Hussein MN, Meesters EW, Osmanovic N, Romijn FP, Nieuwland R, and Sturk A. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost 1: 2434-2443, 2003.
2. Ahn YS, Jy W, Jimenez JJ, and Horstman LL. More on: cellular microparticles: what are they bad or good for? J Thromb Haemost 2: 1215-1216, 2004.
3. Bernal-Mizrachi L, Jy W, Fierro C, Macdonough R, Velazques HA, Purow J, Jimenez JJ, Horstman LL, Ferreira A, de Marchena E, and Ahn YS. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 97: 439-446, 2004.
4. Biro E, Nieuwland R, and Sturk A. Measuring circulating cell-derived microparticles. J Thromb Haemost 2: 1843-1844, 2004.
5. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, and Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649-2652, 2001.
6. Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V, D'Ercole C, and Dignat-George F. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost 89: 486-492, 2003.
7. Brodsky SV. Coagulation, fibrinolysis and angiogenesis: new insights from knockout mice. Exp Nephrol 10: 299-306, 2002.
8. Brodsky SV, Malinowski K, Golightly M, Jesty J, and Goligorsky MS. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 106: 2372-2378, 2002.
9. Brodsky SV, Zhang F, Nasjletti A, and Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286: H1910-H1915, 2004.
10. Carmeliet P and Collen D. Molecular analysis of blood vessel formation and disease. Am J Physiol Heart Circ Physiol 273: H2091-H2104, 1997.
11. Staton CA, Stribbling SM, Tazzyman S, Hughes R, Brown NJ, and Lewis CE. Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85: 233-248, 2004.
12. Chen J, Brodsky S, Li H, Hampel DJ, Miyata T, Weinstein T, Gafter U, Norman JT, Fine LG, and Goligorsky MS. Delayed branching of endothelial capillary-like cords in glycated collagen I is mediated by early induction of PAI-1. Am J Physiol Renal Physiol 281: F71-F80, 2001.
13. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, Mutin M, Sanmarco M, Sampol J, and Dignat-George F. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104: 93-102, 1999.
14. Diamant M, Tushuizen ME, Sturk A, and Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 34: 392-401, 2004.
15. Dougherty ER. Hands-on Morphological Image Processing. Bellingham, WA: SPIE Press, 2003.
16. Folkman J. Angiogenesis and apoptosis. Semin Cancer Biol. 13: 159-167, 2003.
17. Goligorsky MS, Chen J, and Brodsky S. Workshop: endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide. Hypertension 37: 744-748, 2001.
18. Griffioen AW and Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52: 237-268, 2000.
19. Guidolin D, Nico B, Mazzocchi G, Vacca A, Nussdorfer GG, and Ribatti D. Order and disorder in the vascular network. Leukemia 18: 1745-1750, 2004.
20. Guidolin D, Vacca A, Nussdorfer GG, and Ribatti D. A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. Microvasc Res 67: 117-124, 2004.
21. Horstman LL, Jy W, Jimenez JJ, and Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9: 1118-1135, 2004.
22. Hugel B, Martinez MC, Kunzelmann C, and Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20: 22-27, 2005.
23. Jimenez JJ, Jy W, Mauro LM, Horstman LL, and Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 112: 81-90, 2001.
24. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, and Ahn YS. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 123: 896-902, 2003.
25. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, and Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109: 175-180, 2003.
26. Jy W, Minagar A, Jimenez JJ, Sheremata WA, Mauro LM, Horstman LL, Bidot C, and Ahn YS. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci 9: 3137-3144, 2004.
27. Kim BS, Chen J, Weinstein T, Noiri E, and Goligorsky MS. VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. J Am Soc Nephrol 13: 2027-2036, 2002.
28. Kim HK, Song KS, Chung JH, Lee KR, and Lee SN. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 124: 376-384, 2004.
29. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, and Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101: 841-843, 2000.
30. Martinez MC, Tesse A, Zobairi F, and Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 288: H1004-H1009, 2005.
31. Merks RMH, Newman SA, and Glazier JA. Cell-oriented modeling of in vitro capillary development. Lecture Notes in Computer Science 2004, vol. 3305, p. 425-434.
32. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten Have K, Eijsman L, Hack CE, and Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96: 3534-3541, 1997.
33. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, and Ahn YS. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41: 211-217, 2003.
34. Sanz L, Pascual M, Munoz A, Gonzalez MA, Salvador CH, and Alvarez-Vallina L. Development of a computer-assisted high-throughput screening platform for anti-angiogenic testing. Microvasc Res 63: 335-339, 2002.
35. Segura I, Serrano A, De Buitrago GG, Gonzalez MA, Abad JL, Claveria C, Gomez L, Bernad A, Martinez AC, and Riese HH. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis. FASEB J 16: 833-841, 2002.
36. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, and Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160: 673-680, 2002.
37. Taraboletti G and Giavazzi R. Modelling approaches for angiogenesis. Eur J Cancer 40: 881-889, 2004.
38. VanWijk MJ, Boer K, Berckmans RJ, Meijers JC, van der Post JA, Sturk A, VanBavel E, and Nieuwland R. Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents. Thromb Haemost 88: 415-420, 2002.
39. VanWijk MJ, Nieuwland R, Boer K, van der Post JA, VanBavel E, and Shirk A. Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol 187: 450-456, 2002.
40. Vanwijk MJ, Svedas E, Boer K, Nieuwland R, Vanbavel E, and Kublickiene KR. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 187: 1686-1693, 2002.
41. VanWijk MJ, VanBavel E, Sturk A, and Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 59: 277-287, 2003.